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ABSTRACT
Numerous clinical studies have indicated, based on mortality rates, that methicillin-resistant Staphy-
lococcus aureus (MRSA) strains are more virulent than methicillin-susceptible S. aureus (MSSA) strains. In
contrast, quantitative laboratory examinations of the presence and magnitude of pathogenic
mechanisms and virulence factors in strains of MRSA and MSSA have generated conflicting data.
The most important reason for these conflicting results is probably the heterogeneic nature of the
resistant population. A comparison of selected and congenic MRSA and MSSA sub-populations of the
same strain is required to resolve this issue.
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The possible differences in pathogenicity and
virulence among strains of methicillin-resistant
Staphylococcus aureus (MRSA) and methicillin-
susceptible S. aureus (MSSA) form an as yet
unresolved problem. What factors contribute to
virulence? On one side is the patient’s ability to
respond to infecting bacteria; on the other are the
virulence factors produced by the bacteria, e.g.,
adhesins, toxins and various enzymes.
Methicillin resistance is encoded by the mecA
gene, located on a genomic island termed the
staphylococcal cassette chromosome mec
(SCCmec) element, which itself has five distinct
types. SCCmec is a mobile genetic element that is
capable of exchange between different staphylo-
coccal species [1,2]. Clinical data concerning
length of hospitalisation, mortality rate and hos-
pital costs related to MSSA and MRSA infections
suggest a greater burden for MRSA infections.
Patients for whom appropriate therapy is delayed
have a significantly increased risk of developing
MRSA bacteraemia, and their clinical response is
slower than that of patients with MSSA bacterae-
mia [3]. However, the sample size, the various
patient populations with different underlying
diseases, and differences in antibiotic use can all
be postulated as confounding factors in such
situations. Adjustment for disease severity and
co-morbid conditions is crucial in order to obtain
a more objective understanding concerning the
clinical significance of methicillin resistance [3–6].
According to Cosgrove et al. [4], the enhanced
virulence of MRSA and the decreased effective-
ness of vancomycin, which is invariably used to
treat MRSA infections, coupled with the delay in
selection of a microbiologically appropriate anti-
biotic regimen, are the potential reasons why
MRSA infections may be associated with higher
mortality [4].
Another aspect relates to whether the S. aureus
infection is epidemic or sporadic. A lower mor-
tality rate was found for MRSA in an outbreak
situation when compared with a non-outbreak
situation. This observation can perhaps be
explained by a greater suspicion of MRSA infec-
tion and earlier use of adequate empirical therapy
in the outbreak situation [4]. In addition, the
immunological status and the risk-factors of the
patients in whom manifest, life-threatening
MRSA infections occur must be considered. Most
such patients have been immunologically com-
promised and have underlying diseases. So why
is MRSA more virulent than MSSA?
Comparative in-vitro studies of heteroresistant
MRSA and non-heteroresistant MSSA clinical
isolates have investigated protein A-, fibrinogen-,
fibronectin-, collagen- and vitronectin-binding
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proteins. The results were not consistent with
respect to the frequency and content of these
adhesins, either in the MRSA or in the MSSA
strains [7–10]. Similarly, the magnitude of binding
to epithelial cells and plastic surfaces did not differ
significantly betweenMRSA andMSSA strains [7].
Results concerning the incidence and amount of
enterotoxins produced are also conflicting,
although it was thought originally that production
of enterotoxin B was associated with methicillin
resistance. The situation concerning the produc-
tion of cytotoxins is similar [11,12]. The presence
of Panton–Valentine leukocidin genes has also
been investigated, but the results for different
MSSA and MRSA strains were also conflicting.
Panton–Valentine leukocidin is a bicomponent
pore-forming cytotoxin that is used as a marker of
community-acquired MRSA infections. It is now
widely accepted that MRSA is not just a nosoco-
mial pathogen, and MRSA strains involved in
community-associated infections have a world-
wide distribution [13–15]. Phagocytosis assays
have also failed to yield consistent results, in that
MRSA and MSSA strains were equally susceptible
to phagocytes [10].
All of these conflicting results can be attributed
to the varying heterogeneity of the individual
strains studied so far. It is also important to note
that the above-mentioned clinical and in-vitro
studies focused on phenotypic characteristics and
did not always detect the genes encoding these
virulence factors. Most MRSA strains actually
consist of a heterogeneous population of cells,
composed of methicillin-sensitive, borderline-
resistant and methicillin-resistant (MR) sub-pop-
ulations. In the MR sub-population, the cocci have
an enhanced level of resistance to methicillin.
Such cells occur at a frequency of only 1 in
104)105. Data derived from experiments with
such heterogeneous isolates mostly concern the
susceptible majority of the population rather than
the MR sub-population. Thus, when comparing
MSSA and MRSA strains, congenic MSSA and
MRSA strain pairs derived from the same isolate
should be examined to obtain meaningful results.
To date, few studies have compared congenic
MRSA and MSSA sub-populations derived from
the same strain. However, the results available
show fundamental differences between MRSA
and MSSA cells, with MRSA cells possessing
significantly higher quantities of lipids of all
classes than do MSSA cells. Electron-microscopic
examinations have shown that the separation of
MRSA daughter cells along the cross-walls is
delayed, but that the formation of new cross-walls
occurs more quickly, resulting in multi-septated
cocci. In contrast, the division of MSSA occurs
regularly in two planes, while the separation of
MRSA has three planes [16,17]. MSSA cocci have
a shorter generation time, resulting in a higher
cell count within an hour, than that of MRSA [16].
The log phase of MRSA has been found to be
c. 5 h longer than that of MSSA with the same
inocula [17]. This is probably caused by the
enhanced septation and retarded separation of
the MR cells. Thus, proliferation kinetics may
reflect differences in virulence.
In-vivo animal models may also reveal charac-
teristic differences between congenic MRSA and
MRSA cells. A higher number of MRSA cells was
required to cause the same rate of death in Balb ⁄ c
mice as that caused by congenic MSSA cells [18].
In contrast, the persistence of MRSA cells in the
organs of surviving mice was twice that of the
congenic MSSA cells [19]. These results indicate
that both bacterial populations are virulent for
mice, but that the mechanism(s) of pathogenesis
of MRSA and MSSA infections may be different.
The main objective difference between MRSA
and MSSA cells remains the antibiotic suscepti-
bility pattern. MRSA cells are resistant to all b-
lactam antibiotics, and can acquire resistance to
other antibiotics easily, leading to the develop-
ment of multiresistant strains. Multiple drug
resistance might play a role as an indirect viru-
lence factor by providing a selective advantage
for MRSA cells [20].
In conclusion, the data available in the litera-
ture do not, as yet, unequivocally support the
hypothesis that MRSA strains are more virulent
than MSSA strains. The most important reason
for the conflicting results is probably the hetero-
geneic nature of the resistant population. Further
investigations with congenic MRSA and MSSA
strains are required to correlate the genetic
background with the phenotypic expression of
virulence. Such investigations would better mi-
mic many clinical situations, since manifest infec-
tions are, of necessity, treated empirically with
standard antibiotics to which the MR sub-popu-
lation is usually resistant. As a consequence, an
MRSA sub-population is selected and may
become predominant, which then determines
the subsequent clinical response.
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